Asthma and Allergy Flashcards

1
Q

What is the defining pathological feature of asthma?

A

Reversible bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 types of asthma?

A

Atopic or allergic asthma
Non-allergic asthma
Others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between allergic and non-allergic asthma?

A

In allergic asthma, serum IgE is elevated and there are specific external triggers
In non-allergic asthma, serum IgE is normal and there are non-specific triggers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the basic pathological mechanism in atopic asthma?

A

Trigger stimulates mast cells via cross-linking of IgE
Mast cells release mediators (e.g. histamine)
Mediators cause acute increased vascular permeability, increased mucus production and bronchospasm
Mediators also lead to a late-phase response which includes chemotaxis of eosinophils, mast cells, lymphocytes and macrophages, contributing to ongoing inflammation and epithelial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some of the short term complications of asthma?

A

Death
Atelectasis (lung collapse or closure)
Spontaneous pneumothorax and/or pneumomediastinum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is pneumothorax?

A

Abnormal collection of gas or air in the pleural space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some of the changes that occur in severe chronic asthma?

A

Airway remodelling with fibrosis and irreversible obstruction
Chronic hypoxia leading to pulmonary hypertension and cor pulmonale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is status asthmaticus?

A

Acute severe asthma attack which does not respond to bronchodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What immediate changes occur on the cellular level following activation of the FcER1 receptor?

A

B and y chains of the FcER1 are phosphorylated via ITAMs (immunoreceptor tyrosine-based activation motifs)
When receptors are aggregated by cross-linking, they migrate via lipid rafts and recruit kinases to initiate an intracellular signalling cascade
Phospholipase C is phosphorylated and activated, resulting in production of DAG/IP3
DAG activates PKC and IP3 mobilises Ca2+ to produce degranulation of the mast cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is FcER1?

A

High-affinity IgE receptor present on mast cell membranes and responsible for allergen-induced mast cell degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the immediate response of mast cells to stimulation?

A

Release of preformed mediators within 30-45 secs

Preformed mediators include histamine, heparin (anti-coagulant), tryptase (protease activator) and TNF-a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the delayed response of mast cells to stimulation?

A

Production and release of Cys-LTs and PGD2

Onset within 5-10 mins with a peak at 10-30 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the delayed and protracted response of mast cells to stimulation?

A

Transcription, translation and release of cytokines, including IL-4, IL-5 and GM-CSF, within hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List 8 important actions of histamine, making note of what receptor is responsible for each

A

Pain and itch (H1)
Bronchospasm (H1)
Mucus secretion (via goblet cell activation; H1)
Vasodilation leading to hypotension and oedema (H1)
Increased vascular “leak” leading to hypovolaemia (H1)
Increased wakefulness in the CNS (H1)
Positive inotropic (force of contraction) and chronotropic (HR) actions (H2)
Gastric acid secretion (H2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What activates 5-lipoxygenase in allergy?

A

Increased IC Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which Cys-LTs are active at the CysLT1 receptor?

A

LTC4, LTD4, LTE4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the role LTB4 in asthma?

A

Promotes leukocyte chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Montelukast

A

CysLT1 receptor antagonist used prophylactically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the role of Cys-LTs in asthma?

A

Potent bronchoconstrictors

Increased vascular “leak”, leading to oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

List 3 endogenous inhibitors of mast cell activation

A

PGE2
Adrenaline
Cortisol

21
Q

What is the role of annexin-1?

A

Resolves inflammation

22
Q

Omalizumab

A

Monoclonal antibody to alpha chain of FcER1 used to inhibit mast cell activation in asthma

23
Q

Why are NSAIDs and COX-2 selective inhibitors not used in the treatment of asthma?

A

Prostaglandins have a mixed role in asthma (beneficial and detrimental)
May provoke symptoms due to excess production of LTs

24
Q

Zafirlukast

A

Orally active Cys-LTRA

25
Q

What are Cys-LTRAs especially indicated for?

A

Aspirin- and exercise-induced asthma

Allergic rhinitis

26
Q

What is the difference between the role of relievers and controllers in asthma vs. preventers?

A

Reliever and controllers only act on bronchoconstrction

Preventers also act on oedema and mucus hypersecretion

27
Q

What changes do contractile agonists (e.g. histamine, Cys-LTs) produce to regulate smooth muscle tone in asthma?

A

Increased frequency of Ca2+ waves

Activation of Rho kinase and PKC

28
Q

What histological changes occur in asthma?

A
Goblet cell metaplasia
Subepithelial collagen thickening
Infiltration of inflammatory cells
Increased mucosal vascularity
Increased smooth muscle volume
29
Q

What are relievers?

A

SABAs (B2-selective) with an onset within minutes

30
Q

Salbumatol

A

SABA

31
Q

Terbutaline

A

SABA

32
Q

Adverse effects of SABAs

A

Tachycardia
Tremor
Hypokalaemia

33
Q

Limitation of SABAs

A

Tolerance; regular use may increase morbidity and mortality

34
Q

What is the cellular mechanism by which SABAs counter contractile agonists in asthma?

A
Increase Ca2+ reuptake
Activates PKA (which decreases Ca2+ waves and activates MLC phosphatase)
35
Q

What are controllers?

A

LABAs with slow or rapid onset but long duration (12-24 hrs)

36
Q

Salmeterol

A

LABA

37
Q

How are LABAs administered?

A

Co-administered with GCS in a single actuator

38
Q

Ipratropium bromide

A

Non-selective SAMA

39
Q

Tiotropium bromide

A

Functionally M3-selective LAMA

40
Q

How are muscarinic antagonists administered?

A

Co-administered with SABAs and LABAs

41
Q

What is the result of transactivation by GCS?

A

Dimerised GCS receptor binds GCS response element (GRE) and stimulates transcription of B2-adrenoceptors, annexin-1 and serpin A3

42
Q

What is serpin A3?

A

Inhibitor of serine proteases

43
Q

What is the result of transrepression by GCS?

A

Monomer of GCS receptor complex binds pro-inflammatory TFs (e.g. NFkB, AP-1) and prevents transcription of pro-inflammatory cytokines, inducible enzymes and adhesion molecules

44
Q

When are inhaled GCS indicated in asthma?

A

With B2 agonist use >3 times/week

45
Q

Fluticasone proprionate

A

Inhaled GCS available in combination with LABA

46
Q

Beclomethasone diproprionate

A

Inhaled GCS available in combination with LABA

47
Q

When are systemic GCS indicated in asthma?

A
Acute exacerbations (for few days only)
Chronic administration only in severe asthma
48
Q

How is asthma treated based on severity?

A

Very mild: SABA as required
Mild: low dose inhaled GCS + SABA as required
Moderate: higher dose inhaled GCS + SABA as required
Severe: high dose inhaled GCS, SABA as required, LABA, oral GCS + muscarinic antagonist